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Introduction 
Immune response: the forfeit for surviving 
Plants and animals are constitutively exposed to various microbes present in the 
environment including commensal and pathogenic microorganisms. Despite the perpetual 
presence of pathogens, infections still develop infrequently, because all multicellular 
organisms have evolved defense mechanisms to combat against harmful microbes [1]. 
The highly organized mammalian immune system can be divided into innate and 
adaptive (acquired) immunity. The innate immune system denotes an evolutionary more 
conservative, however less specialized defense mechanism. The non-specific effector 
cells (i.e. epithelial cells, such as keratinocytes) can eliminate invading pathogens and 
attract specific effector cells (i.e. macrophages, dendritic cells (DCs)) to the site of the 
infection by the secretion of pro-inflammatory mediators, such as cytokines and 
chemokines. The cellular elements of the innate immunity recognize and respond to 
pathogens in a generic way although it does not confer long-lasting protective immunity 
to the host. On the other hand, the adaptive immune response exhibits a more 
sophisticated and complex mechanism than the innate immunity with the ability to 
recognize and remember specific pathogens/antigens which finally results in a more 
pronounced immune response after the re-infection with the respective pathogen/antigen. 
Hence, for the development of immunological memory antigen presentation is essential. 
For this, professional antigen presenting cells (APCs, such as dendritic cells) take up 
invading pathogens at the periphery and after migrating to lymphoid organs they present 
antigens primarily to T lymphocytes. Antigen presentation to naïve T lymphocytes is 
called as lymphocyte activation. This activation process leads to the clonal expansion of 
the effector T lymphocytes which makes cells capable for fighting against pathogenic 
microbes in a microbe specific way. Taken together, the successful activation of both the 
innate and the adaptive immune system finally results in the elimination of the invading 
pathogens, which is essential for the host’s survival (Figure 1). 
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Figure 1. Time course and different processes involved upon the activation of innate (green panels) 
and adaptive (orange panels) immune response. 
Beside secreting cytokines and chemokines, epithelial cells are also forming tight 
junctions which serve as an effective mechanical barrier between the host and the 
environment. This is particularly important as the members of the commensal microflora 
are present on epithelial surfaces, such as the gut and skin. On the epithelial surfaces, the 
commensal microflora occupies niches which are suitable for bacterial growth and they 
create special environment, where pathogens are not able to grow [2]. Epithelial cells are 
also capable for producing cationic antimicrobial peptides, for example psoriasin, 
cathelicidin (LL-37), ribonuclease 7 and numerous defensins [3] [4], which all have direct 
antimicrobial activity, thereby controlling commensal microflora. 
The control of Staphylococcus aureus (S. aureus) infection 
In order to induce the appropriate immune response, the host must detect the 
invading pathogens first, primarily through the pattern recognition receptors (PRRs). The 
best characterized PRRs are the Toll-like receptors (TLRs) which recognize a wide 
variety of pathogen-associated molecular patterns (PAMPs, such as peptidoglycan; PGN) 
expressed by microorganisms including viruses, bacteria, fungi and protozoa [5] [6]. In 
addition to PAMPs, endogenous host-derived danger signals (danger-associated 
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molecular patterns; DAMPs) like heat-shock proteins, hyaluronan and other degradation 
products from necrotic tissues can activate the TLRs [7], [8]. 
Although Staphylococcus aureus (S. aureus) is the member of the normal microflora 
of the skin and the nasal passage, moreover 20% of the human population are long-term 
carriers of the bacteria [9], S. aureus is responsible for the majority of skin infections 
[10].  
As the Staphylococcal cell wall is mostly composed by PGN [11], PGN is the most 
potent PAMP of S. aureus, inducing the host’s immune response by cross-linking the 
TLR2. Figure 2 shows a simplified scheme of signaling pathway induced by ligand 
stimulation of the representative TLRs. Briefly, the activation of TLR2 with PGN induces 
the MyD88-dependent signaling cascade which finally results in the activation of NF-κB. 
Together with the activation of ERK, JNK and p38, this leads to the enhanced production 
of effector molecules, such as IL-12p40, IL-1 and TNF-α. In this process, TIRAP controls 
MyD88 activation and also regulates the phenotypic maturation of dendritic cells by 
increasing the expression of CD40, CD80 and CD86 on the cell surface [12]. 
 
Figure 2. The cross-linking of TLRs with its respective ligand is essential for pro-inflammatory 
mediator production and dendritic cell maturation [12]. 
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Tolerance to LPS is essential for the control of inflammation 
As the inflammation causes dramatic changes in tissue physiology, inflammatory 
responses must be strictly regulated because uncontrolled inflammation could lead to 
serious pathologic conditions such as septic shock, autoimmunity, atherosclerosis, etc 
[13]. On the other hand, there are a wide variety of regulatory mechanisms built in the 
TLR4-mediated signaling pathway, such as the production of anti-inflammatory 
cytokines, and the induction of the negative regulators of the TLRs, i.e. SOCS1[14],[15] 
TNFAIP3 [16] preventing the host from the harmful side effects of the uncontrolled 
inflammation. 
These molecules have pivotal role in the long-lasting hyporesponsiveness of the cells 
and organisms to prolonged/repeated LPS stimulation, which phenomenon is called as 
LPS tolerance [17], [18]. For a long time LPS tolerance was thought to be a consequence 
of receptor desensitization[19], [20]. Recently, Foster et al. demonstrated that the 
transient silencing of pro-inflammatory genes at chromatin level also has essential role in 
the maintenance of LPS tolerance [21]. They treated primary mouse macrophages with 
LPS once or repeatedly and they examined the relative gene expression of inflammatory-
related genes. In brief, they found that cytokines such as IL-6 or IL-1β were up regulated 
after the first LPS stimulation, however they were not re-induced or induced to a much 
lesser degree after the second LPS challenge (defined as tolerizeable). In contrary to 
cytokines, the relative gene expression of antimicrobial peptides (i.e. cathelicidin-related 
antimicrobial peptide) seemed to be inducible after the second LPS treatment (defined as 
non-tolerizeable) in order to protect the host from the impending pathogens and the tissue 
damage caused by uncontrolled inflammation. The more accurate analysis demonstrated 
that covalent histone modifications have important role in the maintenance of LPS 
tolerance. After investigating the promoters of tolerizeable and non-tolerizeable genes, 
Foster et al. found that although the promoters of both classes were inducibly acetylated 
(this is characteristic for transcriptional activity) in naïve macrophages, only the non-
tolerizeable promoters were re-acetylated after LPS treatment in tolerant cells. 
Dendritic cells: gatekeepers between innate and adaptive immune response 
As mentioned earlier, professional APCs are essential for the induction of the 
adaptive immune response. Figure 3 demonstrates that dendritic cells serve as a bridge 
between innate and adaptive immunity. In the periphery, DCs function as immune 
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sentinels, because they are able to sense threatening pathogens by their PRRs [22] which 
is followed by phagocytosis and clathrin mediated endocytosis in order to take up 
invading pathogens [23]. Soon after pathogen uptake, DCs migrate to lymphoid organs, 
for example lymph nodes, spleen, etc. In lymphoid organs, DCs complete their maturation 
processes and attract T lymphocytes by the elevated production of cytokines and 
chemokines. By the up regulation of major histocompatibility complex (MHC) II DCs are 
able to present processed pathogenic antigens to T lymphocytes through T cell receptors 
(TCRs) [24] which finally leads to the activation of the adaptive immune response. 
 
Figure 3. Dendritic cells serve as a bridge between innate and adaptive immunity [25] 
The majority of DCs function as immune sentinels at the periphery i.e. in the skin 
where they called Langerhans cells. Because DCs only constitute the minority of the 
peripherial blood form where their separation is almost impossible, the investigation of 
human DCs is based on DC differentiation strategies from DC precursors which finally 
results in a usable ex vivo model system  [26]. 
For this, CD14
+
 monocytes are most frequently used as precursors for DC 
differentiation. In the presence of recombinant granulocyte-macrophage colony 
stimulating factor (GM-CSF) and interleukin-4 (IL-4) IL-4-DCs are generated [27]. Other 
research groups reported that CD14
+ 
monocytes stimulated with recombinant GM-CSF 
and interferon-α (IFN-α) differentiated into IFN-DCs. Further analysis of both cells 
confirmed immature DC phenotype (iDC) which is characterized by a moderate 
expression level of costimulatory molecules like CD83 and CD25 [28], [29] and 
conserved phagocytic capacity. 
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It is also possible to generate mature dendritic cells (mDCs) from iDCs by treating 
them with TNF-α, IL-1, or challenging them with microbial agents. mDCs are 
characterized with elevated pro-inflammatory cytokine production, increased 
antimicrobial response and enhanced antigen presenting capacity [30]. 
DCs in health and disease 
It is important to note that the role of DCs is not limited to the initiation of the 
adaptive immune response. In some pathologic conditions, the function of DCs is 
disturbed, and they induce immune response against self molecules. This process is called 
autoimmunity, which often results in serious, multi-organ autoimmune diseases, such as 
systemic lupus erythematosus (SLE) [31], or psoriasis [32]. 
Psoriasis is one of the most common multifactorial autoimmune-like disease 
worldwide, as it affects approximately 2% of the population. This chronic disease mainly 
affects the skin, however severe joint destructions (psoriatic arthritis) and nail alterations 
could be detected beside skin discrepancies [33]. 
As a multifactorial disease environmental factors like microbial infections, trauma or 
stress initiate psoriasis development in genetically susceptible individuals. Environmental 
stimulation leads to the release of self DNA and RNA from stressed keratinocytes which 
form complexes with LL-37 antimicrobial peptide. This complex activates DCs through 
their TLR7 and TLR9 receptors [34], [35] and leads to the production and the release of 
pro-inflammatory mediators such as IFN-α. The enhanced local level of IFN-α together 
with GM-CSF stimulates monocytes to differentiate into DCs [36]. IFN-α primed DCs 
than transform naïve T lymphocytes into Th1 and Th17 cells which migrate to the skin 
where they have central role in the initiation of psoriatic plaque formation, partly by 
elevated pro-inflammatory cytokine secretion [37]. 
The malfunction of the skin’s immune system in psoriasis induces massive 
mononuclear leukocyte (T lymphocyte, neutrophils, plasmacytoid DCs and CD11c
+
 DCs) 
infiltration compared with normal, non-lesional skin biopsy samples (Figure 4). CD11c
+
 
DCs from psoriatic lesions express high level of TNF-α and inducible nitric oxide 
synthase (iNOS) both playing central role in pathogen elimination. In addition to TNF-α 
production, CD11c
+
 DCs secrete T cell and keratinocyte activating cytokines, such as IL-
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23 and IL-20, respectively. The elevated amount of maturation markers suggest that these 
DC types are able to present antigens to T lymphocytes. 
 
Figure  4. Massive immune cell infiltrations and epidermal hyperproliferation characterize psoriasis 
[38]. 
The enhanced pro inflammatory cytokine and chemokine production by professional 
immune cells finally leads to massive keratinocyte hyperproliferation in psoriatic lesional 
skin biopsy samples. Furthermore, psoriatic keratinocytes are resistant to apoptotic 
signals, and their survival mechanisms are up regulated, thus histologic analysis represent 
robust epidermal expansion (acanthosis). Moreover, the absence of the granular layer 
leads to incompletely differentiated keratinocytes (parakeratosis) which is another 
hallmark of psoriasis [38]. 
Psoriasis treatment strategies  
Investigations of psoriasis at a molecular level demonstrated the up regulation of a 
wide variety of pro-inflammatory mediators. Thus, both conventional and biologic 
therapeutics approaches target the immune system. Conventionally immunosuppressive 
therapies include classical systemic (methotrexate, cyclosporins, retinoids) or topical 
treatment (anthralin, corticosteroids, salicylic acid, vitamin D analogues) and/or 
phototherapy (climatoterapy, broadband UVB, narrowband UVB and psoralen with 
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ultraviolet A radiation (PUVA)) are applied (Figure 5). As these conventional treatment 
strategies are based on the global suppression of the immune system, often serious, 
sometimes life-threatening side effects are detected [39], [40], [41], [42]. 
On the other hand, the inhibition of the respective pro-inflammatory mediators with 
antibodies or soluble receptors became the mainstream of biologic therapy. The right 
panel of Figure 5 contains those biologic agents which are accepted or are at the approval 
stage. TNF- α is the main cytokine involved in the pathogenesis of psoriasis, most part of 
the biologic therapy agents target this cytokine, although the prevalent usage of the TNF- 
α blocking agents can cause gastrointestinal symptoms or liver damage [43]. Yet, TNF- α 
blockers are became the world’s top selling medicines in 2012. 
Based on the fact that Th17 cells have pivotal role in the pathogenesis of psoriasis, 
IL-17 blocking antibodies are also under extensive study. Ixekizumab [44] and 
secukinumab [45] are antibodies against IL-17, however brodalumab [46] is a soluble IL-
17 receptor, but all of them are successfully used to treat moderate to severe plaque type 
psoriasis. In order to treat psoriasis, some other cytokines such as IL-23 and IL-22 can 
also be hampered by blocking antibodies in order to repress the elevated cytokine 
production of Th17 cells. 
 
Figure 5. Conventional treatment strategies and biologic therapies are used in psoriasis [43], [33], 
[47]. 
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Transcriptome analysis 
In microarray experiments cDNA is hybridized on an array of complementary 
oligonucleotide probes corresponding to the gene of interest, and the relative abundance 
of mRNA is estimated from its hybridization capacity to the relevant probe [48]. However 
one drawbacks of this approach is the limited number of probe sets included on the chip. 
Recently launched technology, called next generation sequencing (NGS) has rapidly 
substituted microarray due to, among others, it has improved accuracy and throughput 
and decreased cost-per-experiment ratio. Beside de novo sequencing of genomes, NGS 
technology is also very powerful when it comes to genome resequencing, SNP, MNP and 
indel identification [49]. Furthermore, NGS offers an unprecedented opportunity to 
jointly analyze cellular transcriptional activity without any information of the nature of 
the transcript. 
One of these applications is the whole transcriptome sequencing (RNA-Seq). During 
this application, ribosomal RNA is removed from total RNA and the RNA leftover is 
fragmented by RNAseIII restriction enzyme. The RNA fragments are size selected and 
the 50-200 nucleotide long fractions are used for library preparation followed by 
sequencing. This gives a unique opportunity to detect all the expressed exons of the 
respective genes, but also to detect new splice variants and to identify novel, unannotated 
exons. 
In order to analyze alterations at mRNA level, another approach, called serial 
analysis of gene expression followed by sequencing (SAGE-Seq; also known as digital 
gene expression tag profiling; DGE) can be used. This method is based on the capture of 
polyadenylated mRNAs by oligo(dT) containing magnetic beads only the captured 
mRNA is sequently analyzed. Compared with the traditional serial analysis of digital 
gene expression (SAGE) [50] SAGE-Seq gives remarkably higher data correlations 
between libraries. 
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Aims 
The aims of our investigations were 
 To get a global view on the relative gene expression changes of primary 
human immature dendritic cells (iDCs) upon challenging them once or 
repeatedly with S. aureus derived PGN, a widely used TLR2 ligand. 
 To carry out pathway analysis based on the results of SAGE-Seq 
experiments in order to investigate the impact of PGN challenge on gene 
sets and signaling pathways. 
 To compare the relative gene expression pattern of the selected genes 
between immature and mature dendritic cells (mDCs). 
 To examine the gene expression pattern of selected genes on skin biopsy 
samples. 
 To investigate the impact of soluble TNF-α antibody on the relative gene 
expression of selected genes. 
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Materials and methods 
In vitro generation of primary human dendritic cells 
Human peripherial blood mononuclear cells were isolated from buffy coats of 
healthy individuals (Hungarian Red Cross) by Ficoll Paque Plus (GE Healthcare) density 
gradient centrifugation as previously described [51]. In brief, PBMCs were allowed to 
adhere for 2 hours on each wells of a 6–well plate (Sarstedt). Adherent monocytes were 
washed extensively with pre–warmed phosphate–buffered saline (PBS, Gibco) in order to 
remove non–adherent cells (macrophages, lymphocytes, etc.). iDCs were obtained from 
monocytes by cultivating them in RPMI-1640 medium (Gibco) which was supplemented 
with 10% heat–inactivated foetal bovine serum (FBS, Gibco) and 1% penicillin/ 
streptomycin solution (Gibco) in the presence of 1000 unit/ml recombinant human 
granulocyte–macrophage colony stimulating factor (GM-CSF, Sigma) and 1000 unit/ml 
recombinant human interferon–α (IFN–α, Sigma) for 5 days. mDCs were obtained from 
iDCs by 10 ng/ml recombinant human tumor necrosis factor–α (TNF–α, R&D Systems) 
stimulation for 24 hours. Cells were maintained at 37
o
C in an atmosphere of 5% (v/ v) 
CO2 in air.  
Stimulation of DCs and sample collection 
Both iDCs and mDCs were treated with Staphylococcus aureus (S. aureus) derived 
peptidoglycan (PGN, Sigma) according to the model described on Figure 6. Briefly, iDCs 
and mDCs were left untreated (hereafter defined as naive, N) or stimulated with 10μg/ml 
PGN once (hereafter defined as N+PGN) or twice (hereafter defined as T+PGN), in order 
to mimic acute or persistent infection, respectively. 
 In some experiments, soluble chimeric monoclonal anti-TNF-α antibody (infliximab, 
Remicade, Schering-Plough) was added to primary monocytes in parallel with GM-CSF 
and IFN-α. Infliximab has a long half life of approximately 10 days, which ensured the 
neutralization of all secreted TNF-α during iDC generation. Moreover, freshly prepared 
infliximab was added to the culture supernatants along with PGN stimulations in order to 
neutralize de novo secreted TNF-α.  
Total RNA and cell culture supernatants were collected at 27 and 48 hours, that is 3 
and 24 hours post-second PGN treatment.  
19 
 
 
Figure 6. The model of acute (N+PGN) and persistent (T+PGN) infection. 
Quantitative reverse transcriptase polymerase chain reaction (QRT-PCR) 
Total RNA was extracted from iDCs and mDCs using RNeasy Plus Mini Kits 
(Qiagen) according to the manufacturer’s instructions. The quality and the quantity of 
extracted RNA were determined using NanoDrop (Thermo Scientific), Qubit (Life 
Technologies) and Bioanalyzer (Agilent) measurements. 
cDNA was synthesized from 100ng of total RNA by using High Capacity RNA to 
cDNA Kit (Life Technologies) according to the manufacturer’s instructions. The relative 
abundance of selected mRNAs is determined by QRT-PCR by using StepOne Plus Real-
Time PCR system (Life Technologies). Reactions were performed by using TaqMan 
Gene Expression Master Mix (Life Technologies) for commercially available TaqMan 
probes (Life Technologies) or Power SybrGreen Master Mix (Life Technologies) for 
SybrGreen based QRT-PCR assays. The primer sets used in QRT-PCR experiments are 
listed in Table 1. As controls we used reaction mixtures without cDNA. All of the 
measurements were performed in duplicate with at least three biological replicates. The 
ratio of each mRNA is relative to 18S rRNA calculated by using the ΔΔCt method. 
20 
 
 
Table 1. Specific exon spanning gene expression assays based on commercially available pre-
designed TaqMan (A) or SybrGreen (B) methods used in QRT-PCR experiments 
RNA extraction from skin biopsy samples 
Shave biopsies from uninvolved and involved skin of psoriatic patients and control 
skin biopsies from the breast and stomach area were collected as described previously 
[52]. After the removal of the subcutaneous tissue, skin biopsies were incubated overnight 
at 4
o
C in Dispase solution (Roche Diagnostics). On the following day, the epidermis was 
separated from the dermis and samples were mounted in 1ml of TRIzol Reagent (Life 
Technologies) to which 400μl chloroform (Sigma) was added and vortexed vigorously. 
Samples were centrifuged at 13000 rpm for 10 minutes and the upper phase was loaded 
onto gDNA eliminator spin columns of the RNeasy Plus Mini Kits (Qiagen). Subsequent 
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RNA extraction and quantification as well as cDNA synthesis and QRT-PCR were 
performed as described above. 
All tissue samples were taken with the patient’s informed consent and the approval of 
the local ethics committee. The study was conducted according to the declaration of 
Helsinki Principles.  
SAGE-Seq 
SAGE-Seq was performed using SOLiD SAGE Kit (Life Technologies) 
according to the manufacturer’s instructions. The summary of the method is described on 
Figure 7. Briefly, purified total RNA was bind to Dynabeads Oligo (dT) EcoP15 
magnetic beads in order to capture polyadenylated RNAs. cDNA was synthesized on the 
magnetic beads by using SuperScript III Reverse Transcriptase and E. coli DNA 
polymerase. Next, NlaIII restriction was performed in order to generate GTAC containing 
sticky end at the complementer DNA strand. Barcode adaptor A (P2 Seq-IA-EcoP15I) 
was ligated which contains an EcoP15 restriction enzyme recognition site and truncated 
internal adaptor sequence. An EcoP15I digestion was carried out in order to cleave the 
construct off from the magnetic beads. EcoP15I restriction also resulted in a 2 base-pair 
long overhanging tag. Adaptor B was ligated to 5’ end of each tag which contains the P1 
primer binding site. Each library was amplified in an emulsion PCR, sequencing beads 
deposited onto sequencing slide and sequenced on SOLiD V4 System (Life 
Technologies). 
 
Figure 7. SOLiD SAGE-Seq workflow 
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Bioinformatic analysis of SAGE-Seq 
For mapping SAGE-Seq tags on the human transcriptome we created virtual libraries 
containing all the possible 18 bases length sequences of ENSEMBL human transcript data 
set (version GRCh37.58) located next to an NlaIII restriction site. Virtual tag libraries and 
the preprocessed and quality filtered SAGE-Seq libraries were uploaded into an in-house 
developed data warehouse. Mappings were done by the relational database engine of the 
data warehouse in a way that only perfect matches over the entire 22bp length of the 18bp 
tag plus 46bp NlaIII restriction site were allowed. During the mapping process, the 
system tracked the so-called multiple mapping events where tags detected in the 
experiments could be assigned to more than one transcript. Statistical comparison of 
SAGE-Seq data from different samples was performed using the Bayesian method [53]. 
In brief, the method performs a key-by-key comparison of two key-count distributions by 
generating a probability that the frequency of any key in the distribution differs by more 
than a given fold factor from the other distribution. The algorithm performs the statistical 
analysis by taking into account that the potential difference in the total size of the tag 
libraries compared. In our analysis we used a 2-fold factor difference of transcript 
expression level as the subject of the Bayesian statistical evaluation. The algorithm 
returns a probability value (P) for each tag describing the chance that the detected count 
numbers represent a fold difference of the tag concentration between the investigated 
samples greater than or equal to 2. The change of the tag expression was accepted as 
significant if P was above 0,95. 
Measurement of secreted cytokine levels 
Harvested cell culture supernatants were centrifuged and the concentrations of 
secreted TNF-α and CCL1 were measured by Quantikine Human Immunoassay Kits 
(R&D Systems) following the manufacturer’s instructions. Serial dilutions of the 
respective recombinant human proteins were used to generate standard curves. The 
optical density of each wells were determined by using microplate reader (FLUOstar 
Optima, BMG Labtech) set to 450nm with a wavelength correction set to 540nm. 
Data representation and statistical analysis 
Data show average ± standard error of the mean. The significance of differences 
between sets of data was determined by Student’s paired t-test or one-way ANOVA 
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following Neuman-Keuls post-hoc test using Graph Pad Prism for Windows. A 
probability value (p) of less than 0,05 was considered significant.  
  
24 
 
Results 
SAGE-Seq studies demonstrate that PGN stimulation and re-stimulation has 
appreciable impact on the gene expression profile of primary human iDCs 
In order to get a global view on the gene expression pattern of primary human iDCs 
after single or prolonged PGN stimulation, SAGE-Seq experiments were performed. 
Bioinformatics analysis of SAGE-Seq data evidenced that single or prolonged PGN 
stimulation resulted in significant alterations of the relative gene expression of altogether 
5411 genes (p<0,05). Between naïve (N) and once stimulated (N+PGN) samples 2840 
genes were found which had significant changes in their expression pattern (Figure 8). 
Importantly, 805 out of 2840 were uniquely characteristic for this category. 3647 genes 
changed their relative gene expression pattern between naïve and twice stimulated 
(T+PGN) samples. 1016 out of 3647 were uniquely characteristic between naïve and 
T+PGN samples. The relative gene expression of 566 genes uniquely changed between 
N+PGN and T+PGN samples. Finally, in this current study we mainly focused on those 
genes, because they represent the differences between acute and persistent Staphylococcal 
infections at a relative gene expression level. 
 
Figure 8. The distribution of those 5411 genes which were differently expressed between naïve (N), 
single (N+PGN) or prolonged PGN (T+PGN) stimulated iDCs 
To characterize the potential relevance of the alterations resulted by single or 
prolonged PGN stimulation, pathway analysis was carried out by BioProc (Table 2A) and 
Kegg (Kyoto Encyclopedia of Genes and Genomes, Table 2B) pathway analysis 
softwares. Although Kegg allows for a more accurate analysis by providing consistent 
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and standardized annotations by linking individual genes to components of the KEGG 
biochemical pathways [54] we used both pathway analysis tools to reduce the possibility 
of false results. 
After single or prolonged PGN stimulation compared with naïve cells both BioProc 
and Kegg analysis resulted in massive enrichment of pathways from the function group 
“Immune response” “Apoptosis” and “Motion”. Importantly, comparison between 
N+PGN and T+PGN samples resulted in more down regulated pathways than up 
regulated from these function groups, which strongly suggest the induction of tolerogenic 
mechanisms after prolonged PGN stimulation. In contrary with “Immune response” 
“Apoptosis” and “Motion”, the pathway analysis of the function group “Cell cycle” and 
“Energy production” demonstrates that single or prolonged PGN stimulation significantly 
down regulates the expression of the members of these function groups. It is important to 
note here that BioProc pathway analysis also demonstrated the induction of several (8) 
pathways from “Cell cycle”. Single or prolonged PGN stimulation also results in the 
induction of a number of other pathways compared with naïve cells, for example 
“Systemic lupus erythematosus” or “Autoimmune thyreoid diseases”. 
 
Table 2. The number of significantly up and down regulated pathways after single or prolonged PGN 
stimulation in iDCs which was performed by BioProc (A) and Kegg (B) pathway analysis 
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Based on the results of the pathway analysis and considering that NlaIII has 
recognition site of approximately every 200-300 nucleotides in the human genome we 
investigated the expression patterns of individual tags (tag represents the short sub-
sequence of a gene which is used to identify gene transcripts in SAGE-Seq experiments; a 
gene may contain more than one tag) (Figure 9). We found that 132 tags out of 427 tested 
were re-inducible, as in N+PGN samples significant gene expression down regulation 
was detected compared with naïve cells, in contrast, we detected gene expression up 
regulation in T+PGN samples compared with N+PGN (Figure 9A). The comparison of 
these results with the pathway analysis demonstrated that “Antigen presentation” and 
pathways from autoimmune diseases such as “Systemic lupus erythematosus” and 
“Autoimmune thyreoid disease” fell into this category (data not shown). Based on the 
results of Foster et. al [21] we were mostly interested in tolerizeable tags (Figure 9B). 
Tolerizeability means that single PGN stimulation results in a robust induction in the 
relative gene expression compared with naïve cells however in T+PGN samples 
significant relative gene expression down regulation was detected compared with N+PGN 
samples. The importance of the decreased relative gene expression level after prolonged 
PGN stimulation plays role in is the prevention of the host against the development of 
serious side effects resulting from uncontrolled inflammation. In this study 181 tags out 
of 427 fell into this pattern category; most of them from the “Toll-like receptor signaling 
pathway”. In contrast, the expression of 40 tags out of 427 monitored were down 
regulated in N+PGN samples compared with naïve cells and a more robust down 
regulation was detected after prolonged PGN stimulation (Figure 9C): the members of 
“Cell cycle” and “Apoptosis” function group fell into this category. Finally, 74 tags out of 
427 tested were robustly up regulated in N+PGN samples as compared to naïve cells and 
a more significant relative gene expression up regulation was detected after prolonged 
PGN stimulation (Figure 9D). Comparing these results with the pathway analysis the 
members of the “Cytokine and chemokine signaling pathway” (the member of the 
function group “Immune response”) fell into this category. 
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Figure 9. The number of tags from each different gene expression pattern groups 
Taken these findings together, our data suggest that our experimental model together 
with SAGE-Seq is a valuable approach to monitor the impact of acute and persistent 
infection. Formerly, microarray experiments were used to globally investigate the impact 
of a given stimulation at a gene expression level, although the results were hardly 
repeatable by other validation procedures. The reason for this is the fact that in 
microarray experiments cDNA is hybridized on an array of complementary 
oligonucleotide probes corresponding to the gene of interest, and the relative abundance 
of mRNA is estimated from its hybridization capacity to the relevant probe [48]; the 
probes, may, however cross-hybridize. Nevertheless, we also aimed to validate the 
SAGE-Seq results on a set of genes. Based on the results of the pathway analysis and 
enrichment studies we have chose members of the “Immune response”, “Apoptosis” and 
“Cell cycle” function group which were more accurately analyzed at relative gene 
expression and secreted protein level by QRT-PCR and ELISA. The validation procedure 
was carried out on mature dendritic cells (mDCs) as well, because the presence of foreign 
antigens and the inflammatory milieu induces DC maturation process. During maturation, 
the antigen processing capacity of DCs decreases while their antigen presentation and 
expression of co-stimulatory molecules increases [55]. We hypothesized that these 
features may result in significant difference in their relative gene expression pattern as 
compared to iDCs after single or prolonged PGN stimulation according to the model 
described at Figure 6. 
PGN stimulation has significant impact on the relative gene expression of 
inflammation-related effector molecules and their respective receptors 
Pathway analysis of SAGE-Seq data demonstrated that PGN stimulation resulted in 
robust gene expression up regulation of cytokines and cytokine receptors. The expression 
of the majority of the cytokines were more robustly up regulated in T+PGN samples 
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compared with N+PGN samples (Figure 9D), however in case of some cytokines 
prolonged PGN stimulation resulted in expression down regulation as compared to 
N+PGN samples. Thus, we first examined the relative gene expression alterations of 
inflammation-related effector molecules and their receptors after single or prolonged 
PGN stimulation by QRT-PCR. 
In iDCs, single PGN stimulation resulted in gene expression up regulation of the 
majority of investigated effector molecules such as CXCL8 (Figure 10B), CCL1 (Figure 
10E), IL-6 (Figure 10F), and IL-17A (Figure 10H) compared with naïve cells. 
Furthermore, in case of all four genes a more robust gene expression up regulation was 
detected in T+PGN samples as compared to N+PGN samples. Surprisingly, although IL-
10 (Figure 10G) has an anti-inflammatory role, single or prolonged PGN stimulation 
caused identical alterations in the relative gene expression pattern with the previously 
mentioned pro-inflammatory effector molecules. In mDCs we detected the same relative 
gene expression patterns as for iDCs, however the values of the relative gene expression 
in case of CXCL8 (Figure 10B) and CCL1 (Figure 10E) were less prominent then in 
iDCs.  
Interestingly, the relative gene expression of the neutrophil-attractant chemokine, 
CXCL7 (Figure 10A) was significantly down regulated in N+PGN samples in both iDCs 
and mDCs compared with naïve cells. Uniquely from the function group “Cytokines and 
cytokine receptors” prolonged PGN treatment had no effect on the relative gene 
expression of CXCL7 in neither iDCs nor mDCs compared with naïve cells. 
In contrary to the previously mentioned effector molecules, the IFN-γ inducible 
CXCL9 (Figure 10C) and CXCL10 (Figure 10D) genes showed different expression 
pattern after single or prolonged PGN stimulation. We demonstrated that CXCL9 (Figure 
10C) in mDCs and CXCL10 (Figure 10D) in both iDCs and mDCs are tolerizeable, as 
single PGN stimulation resulted in gene expression up regulation, however prolonged 
PGN stimulation caused robust gene expression down regulation compared with both 
naïve cells and N+PGN samples. Furthermore, in iDCs the relative gene expression of 
CXCL9 (Figure 10C) was significantly down regulated after both single or prolonged 
PGN stimulation compared with naïve cells. 
Because the cytokines show altered gene expression, we aimed to determine the 
impact of PGN stimulation on the relative gene expression pattern of their respective 
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receptors. Our data demonstrate that single or prolonged PGN stimulation significantly 
down regulated the relative gene expression of IL-10RA (the receptor of IL-10, Figure 
10K) and IL-17RA (the receptor of IL-17A, Figure 10L) in both iDCs and mDCs. In 
addition, the same gene expression alterations were detected in the case of gp130 (IL-6 
signal transducer, the receptor of IL-6, Figure 10J) in iDCs, although in mDCs we 
demonstrated the tolerizeability of gp130. Moreover, we detected the tolerizeable 
capacity of CCR8 (the receptor of CCL1, Figure 10I) in both iDCs and mDCs. 
Based on these results which are similar with SAGE-Seq data we concluded that after 
single or prolonged PGN stimulation the host cell maintain critical balance between 
inflammation and tolerance in order to eliminate impending pathogens and to protect the 
host against the harmful side effects resulting from uncontrolled inflammation. 
Furthermore, our data demonstrate the decreased pro-inflammatory cytokine producing 
capacity of mDCs compared with iDCs which phenomenon is strongly supported by the 
fact that mDCs have central role in antigen presentation, in contrast iDCs are mostly 
involved in antigen uptake and the recruitment of other effector cells to the site of the 
infection. Moreover, the investigation of the relative gene expression of the respective 
receptors of inflammation related effector molecules suggests the absence of autocrine 
regulatory mechanisms, as most of the receptors were down regulated. 
 
Figure 10. PGN stimulation significantly modulates the relative gene expression of cytokines, 
chemokines and cytokine receptors in DCs (A: CXCL7; B: CXCL8; C: CXCL9; D: CXCL10; E: CCL1; F: 
IL-6; G: IL-10; H: IL-17A; I: CCR8; J: gp130; K: IL-10RA; L: IL-17RA) Bars show means ± SEM from at 
least 3 independent experiments. * significantly different from the naïve (Student’s paired t-test; p<0,05) 
Pink: iDC; orange: mDC) 
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PGN stimulation has distinct effect on the relative gene expression of TNF-α and the 
members of the TNF-α family 
TNF-α together with IL-1β and IL-6 is an acute-phase protein, which has pivotal role 
in the early immune response against invading pathogens. For example we demonstrated 
that Candida parapsilosis infection results in robust up regulation of TNF-α as soon as 1 
hour after the infection [51].  
QRT-PCR data demonstrated that in both iDCs and mDCs prolonged PGN 
stimulation resulted in robust gene expression down regulation of TNF-α as compared 
with N+PGN samples (Figure 11A). In order to validate this result on translational level 
we carried out secreted TNF-α measurement by ELISA (the sensitivity of the kit is 
between 0-10000 pg/ml) from cell culture supernatants 24 hours post-second PGN 
treatment in order to give enough time for protein translation. ELISA measurement 
supported the relative gene expression data (Figure 11F): in iDCs, PGN stimulation 
resulted in significantly elevated secreted TNF-α level compared with naïve cells. 
Because recombinant TNF-α was used to generate mDCs (see Materials and methods) it 
is not surprising that in mDCs enhanced secreted TNF-α level was detected in cell culture 
supernatants from naïve cells (average secreted TNF-α level: 2661,3966 pg/ml). It is 
important to note here that neither single (average secreted TNF-α level: 2796,28 pg/ml) 
nor prolonged PGN stimulation (average secreted TNF-α level: 2671,58 pg/ml) had 
impact on secreted TNF-α level in mDCs. 
The relative gene expression of TNFSF15 (also known as TL1A; Figure 11D) was 
significantly induced after PGN stimulation in iDCs, although it is not fully understood to 
which pathogens TNFSF15 has evolved to. Thus far, few infectious pathogens has been 
tested in TNFSF15 deficient animal models [56] although we have a much better 
understanding of the pathological role of TNFSF15 in autoimmune diseases such as 
psoriasis [57], in which the authors demonstrated strong nuclear immunopositivity in 
psoriatic skin samples than healthy controls.  
In case of TNFAIP6 (also known as TSG6; Figure 11C) the identical relative gene 
expression pattern was detected as for TNFSF15 (Figure 11D) in iDCs; as PGN 
stimulation resulted in robust relative gene expression up regulation. In mDCs, we also 
demonstrated the PGN-derived up-regulation, however the degree of the up regulation 
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was less prominent as in iDCs. It is important to note that TNFAIP6 is a multifunctional 
protein [58] which is able to interact with the members of the extracellular matrix [59]. 
Previous reports demonstrated that the enhanced TNFAIP6 level is a response to TNF-α 
and IL-1 stimulation and it has essential role in extracellular matrix remodeling, thus it 
emphasizing its role in autoimmune diseases [58]. 
During the elimination of pathogens/antigens immune pathogenesis is a common side 
effect of extended inflammation. To maintain the tissue homeostasis and the transient 
nature of the immune response inflammation must be strictly regulated. Recent studies 
demonstrated that two classes of molecules are required for this process. The first class 
limits the strength of immune activation, these include inhibitory cytokines, negative 
transcription factors and the negative regulators of the TLR signaling [60], [61]. The 
second class includes those molecules which are involved in programmed cell death such 
as Fas, Bim, Bax and caspases [60], [62]. In order to gain insight into the expression 
pattern of negative regulators, we next analyzed the impact of the PGN stimulation on the 
relative gene expression pattern of TNFAIP3 and TNFAIP8. 
The relative gene expression pattern of TNFAIP3 (also known as A20; Figure 11C) 
was similar to TNF-α, as prolonged PGN stimulation resulted in significant relative gene 
expression down regulation in both iDCs and mDCs. In contrast to TNF-α TNFAIP3 is an 
important negative regulator of inflammatory response. This was demonstrated by the fact 
that TNFAIP3 deficient mice die early after the birth due to serious multi-organ 
inflammation [63], furthermore, gene targeting of TNFAIP3 in different cell types was 
shown to be associated with chronic inflammation and autoimmunity [64], [65, 66] . 
In contrary with the previously mentioned members of the TNF-α superfamily, the 
relative gene expression of the negative regulator TNFAIP8 (also known as TIPE2; 
Figure 11E) was significantly down regulated after PGN stimulation in both iDCs and 
mDCs as compared with naïve cells. Moreover, in T+PGN samples a more robust gene 
expression down regulation was detected than in N+PGN samples. Recent reports 
demonstrated that TNFAIP8 is predominantly expressed in immune cells especially in 
monocytes, macrophages and T cells [67], [68], [69], where it negatively regulates T cell 
receptor (TCR) and TLR signaling. The absence of TNFAIP8 expression results in hyper-
responsiveness of TCR and TLR activation and enhanced pro-inflammatory cytokine 
production. This is in line with our findings that prolonged PGN stimulation resulted in 
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significant relative gene expression up regulation in case of CXCL8 (Figure 10B), CCL1 
(Figure 10E), IL-6 (Figure 10F) and IL-17A (Figure 10H) as compared with naïve cells. 
The investigation of the expression pattern of the members of the TNF-α superfamily 
strongly suggests that PGN stimulation results in the significant induction of the pro-
inflammatory mediators, yet we demonstrated the tolerizeable nature of TNF-α and 
TNFAIP3. In contrary with the pro-inflammatory effectors, PGN treatment significantly 
down regulated the relative gene expression of TNFAIP8 compared with naïve cells.  
 
Figure 11. PGN treatment has opposite effect on the relative gene expression of TNF-α and the 
members of TNF-α superfamily in iDCs and mDCs, respectively. (A: TNF-α; B: TNFAIP3 / A20; C: 
TNFAIP6 / TSG6; D: TNFSF15 / TL1A; E: TNFAIP8 / TIPE2; F: secreted TNF-α level from cell culture 
supernatants). Bars show means ± SEM from at least 3 independent experiments. * significantly different 
from the naïve (Student’s paired t test; p<0,05). Pink: iDC; orange: mDC. 
SOCS proteins have function in the regulation of PGN induced inflammation 
The TLR-dependent activation of the innate immunity results in the initiation of a 
pro-inflammatory program to defend the host against the invading pathogen. As pointed 
out, communication between innate and adaptive immune system through cytokines and 
chemokines is essential for the fully functional immune response. The cytokine mediated 
signal transduction must be carefully controlled to avoid the host from immune-
pathologic side effects and to maintain the transient nature of the immune response [70]. 
Beside the previously mentioned negative regulators of the innate immunity from TNF-α 
superfamily, suppressor of cytokine signaling (SOCS) proteins have been identified as an 
inducible inhibitors of cytokine signaling and have these molecules have pivotal role in 
the limitation of the inflammatory responses [71].  
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Beside the down regulation of the immune response, SOCS proteins had also been 
shown to interfere with DC physiology. Hanada et. al. demonstrated that SOCS1 knock-
out DCs showed aberrant activation of the adaptive immune system which finally resulted 
in the induction of autoimmunity [72]. In our experimental model we demonstrated the 
tolerizeable nature of SOCS1 in iDCs (Figure 12A; pink bars). Our findings strongly 
suggest that the down regulation of SOCS1in iDCs after prolonged PGN stimulation 
results in the massive induction of cytokine production which may lead to the 
development of autoimmune diseases.  
Similarly with SOCS1, the tolerizeable nature of SOCS2 was demonstrated in iDCs 
after prolonged PGN stimulation (Figure 12B; pink bars). Uniquely from SOCS proteins 
the relative gene expression of SOCS2 was down regulated in mDCs after single PGN 
treatment compared with naïve cells although the down regulation was not significant 
(p=0,1737) (Figure 12B; orange bars). Moreover, in T+PGN samples we detected a more 
robust gene expression down regulation than in N+PGN samples. It is important to note 
here that Posselt and his colleagues demonstrated that in primary human monocyte-
derived DCs, SOCS2 shows a time-delayed expression pattern after LPS stimulation [73]. 
In that report Posselt et. al also demonstrated that the silencing of SOCS2 results in 
enhanced cytokine production, especially in case of IL-10 and IL-1β [73]. Our results 
corroborate these findings as we detected enhanced relative gene expression of IL-10 
after PGN stimulation (Figure 10G). 
We also examined the impact of single or prolonged PGN stimulation on the relative 
gene expression pattern of SOCS3 which is one of the most potent suppressor of cytokine 
signaling beside SOCS1 [74]. In both iDCs and mDCs PGN stimulation resulted in 
enhanced relative gene expression level of SOCS3 compared with naïve cells. 
The investigations of the expression of SOCS genes with both SAGE-Seq and QRT-
PCR suggest that the enhanced relative gene expression level of SOCS1 and SOCS3 may 
be responsible for the down regulation of pro-inflammatory effector molecules in mDCs 
which, among others, prevents the host against the harmful immune-pathologic side 
effects of extended inflammation. In contrary, the decreased relative gene expression 
level of SOCS1 and SOCS2 in iDCs after prolonged PGN stimulation strongly explains 
the enhanced production of inflammation-related effector molecules and support our 
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hypothesis that ex vivo PGN stimulated iDCs can be used to model the physiology of 
IFN-primed psoriatic DCs. 
 
Figure 12. The members of SOCS family have function in the PGN induced inflammation (A: 
SOCS1; B: SOCS2; C: SOCS3) Bars show means ±SEM from at least 3 independent experiments. * 
significantly different from the naïve (Student’s paired t test; p<0,05) Pink: iDC; orange: mDC. 
Tryptophan deprivation has possible role in the control of Staphylococcal infection 
Beyond the elevated cytokine expression and the induction of the adaptive immune 
response, tryptophan deprivation is another possible mechanism to control 1) pathogenic 
infections [75] and 2) the maintenance of self tolerance [76]. For these, a potential 
mechanism is the over expression of the tryptophan catabolizing enzyme, indolamine 2,3-
dioxigenase (IDO). The enhanced IDO activity suppresses effector T cell responses, 
promotes regulatory T cell differentiation and activation and inhibits IL-6 production by 
DCs [77] [78]. 
Thus, and based on the SAGE-Seq experiments in which we detected the induction of 
tryptophan breakdown, we tested the impact of PGN stimulation on the gene expression 
of IDO (Figure 13B) and kynureninase (Kynu; Figure 13A) which are both involved in 
tryptophan degradation [79]. The relative gene expression of IDO was significantly up 
regulated in both iDCs and mDCs in N+PGN samples and a more pronounced gene 
expression up regulation was detected in both cell types after prolonged PGN stimulation. 
Single PGN stimulation resulted in significant gene expression up regulation in iDCs and 
mDCs in case of Kynu (Figure 13B) compared with naïve cells. After prolonged PGN 
stimulation a more robust relative gene expression up regulation was detected as 
compared with both naïve and N+PGN samples in iDCs. In contrary with iDCs, the 
second PGN stimulation had no impact on the relative gene expression of Kynu in mDCs 
(Figure 13A; orange bars).  
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These data strongly suggest that the over expression of tryptophan catabolizing 
enzymes has role in the control of acute and more interestingly in persistent 
Staphylococcal infection in DCs. 
 
Figure 13. PGN stimulation resulted in elevated relative gene expression of enzymes involved in 
tryptophan catabolism (A: kynureninase, Kynu; B: indolamine 2,3-dioxygenase, IDO). Bars show means 
±SEM from at least 3 independent experiments. * significantly different from the naïve (Student’s paired t 
test; p<0,05). Pink: iDC; orange: mDC. 
PGN stimulation induces cell cycle arrest and resistance to apoptotic process 
The strict regulation of cell division cycle has pivotal role in the maintenance of 
tissue homeostasis and the protection against cancer. As cyclins and cyclin-dependent 
kinases have pivotal role in the transition of different phases of cell cycle we examined 
the impact of PGN treatment on the gene expression of cyclin B2 (CycB2; Figure 14A) 
which is involved in G2-M transition and cyclin D1 (CycD1; Figure 14B) which has 
central role in G1-S transition [80]. 
SAGE-Seq and QRT-PCR demonstrated that single or prolonged PGN stimulation 
resulted in relative gene expression down regulation in case of CycB2 in iDCs (Figure 
14A; pink bars) and in case of CycD1 (Figure 14B) in both iDCs and mDCs. In mDCs we 
demonstrated the tolerizeable capacity of CycB2 (Figure 14A; orange bars):  in N+PGN 
samples moderate gene expression up regulation was detected as compared to naïve cells, 
however prolonged PGN stimulation resulted in gene expression down regulation 
compared to N+PGN samples. 
The induction of apoptotic processes has important role in the maintenance of the 
transient nature of the immune response [60], [61]. We examined the impact of PGN 
stimulation on the relative gene expression of two genes involved in the regulation of cell 
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fate and apoptosis. Fas-associated protein with death domain (FADD, Figure 14C) has 
essential role in the activation of the caspase cascade by cleaving pro-caspase 8 during 
extrinsic apoptotic pathway. In both iDCs and mDCs single and prolonged PGN 
stimulation resulted in significant gene expression down regulation compared with naïve 
cells although we did not find any further difference in the gene expression of FADD 
between N+PGN and T+PGN samples. 
We also examined the impact of single and prolonged PGN stimulation on the 
relative gene expression of transforming growth factor β (TGF-β; Figure 14D). In both 
iDCs and mDCs PGN stimulation resulted in significant relative gene expression down 
regulation as compared to naïve cells, although the relative gene expression of TGF-β 
was up regulated in T+PGN cells than N+PGN samples in iDCs (p=0,0042) (Figure 14D; 
pink bars). 
Taking together both SAGE-Seq and QRT-PCR experiments suggest that, acute and 
persistent Staphylococcal infections decrease cell division cycle by down regulating the 
relative gene expression level of cyclins which have central role in this process. Moreover 
in accordance with SAGE-Seq results, the reduced expression level of pro-apoptotic 
genes suggests the induction of pro-survival mechanisms which may lead to the 
elimination of invading pathogens. 
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Figure 14. PGN challenge results in cell cycle arrest and resistance to apoptotic process (A: cyclin B2, 
CycB2; B: cyclin D1, CycD1; C: Fas-Associated protein with Death Domain, FADD; D: transforming 
growth factor β, TGF-β). Bars show means ±SEM from at least 3 independent experiments. * significantly 
different from the naïve (Student’s paired t test; * p<0,05). Pink: iDC; orange: mDC. 
The relative gene expression of the members of TNF-α super family from psoriatic 
samples show strong correlations with our in vitro model 
Pro and anti-inflammatory members of the TNF-α superfamily maintain critical 
balance during acute and persistent Staphylococcal infection to successfully eliminate 
invading pathogens and to prevent the host against the harmful side effects of 
uncontrolled inflammation (Figure 11). Although the pathogenesis of psoriasis has not 
been fully understood yet, the immunological basis of this disease has been demonstrated 
[81]. Although it is well known that the enhanced level of TNF-α has pivotal role in the 
pathogenesis of psoriasis [82], [83], little is known about the expression pattern of the 
other members of the TNF-α superfamily in this autoimmune disease. In case of 
TNFSF15 a previous report demonstrated strong nuclear immunopositivity in psoriatic 
skin samples, in contrast, TNFSF15 was absent in healthy skin samples [57]. In order to 
determine the relative gene expression pattern of TNFAIP3, TNFAIP6 and TNFAIP8 in 
plaque-type psoriasis we performed QRT-PCR experiments on psoriatic non-leisonal and 
lesional dermal and epidermal samples. As controls, healthy skin biopsy samples were 
used. 
First, we examined the relative gene expression pattern of TNF-α (Figure 15A). We 
found that the relative gene expression level of TNF-α was up regulated in psoriatic non-
lesional epidermal and dermal samples compared with healthy samples (Figure 15A). 
Furthermore, in lesional samples a more robust up regulation was detected than in non-
lesional samples. As these data corroborate earlier findings [84] we used these samples 
for further experiments. 
In accordance with PGN stimulated DCs (Figure 11C) the relative gene expression of 
TNFAIP6 was significantly up regulated in psoriatic non-lesional and lesional epidermal 
samples compared with healthy skin samples ( Figure 15C; blue bars). In non-leisonal 
dermal samples significant gene expression down regulation was detected as compared to 
healthy skin samples, however in lesional samples robust gene expression up regulation 
was detected (Figure 15C; green bars).  
38 
 
In contrary with the pro-inflammatory mediators the anti-inflammatory effector 
molecules, TNFAIP3 (Figure 15B) and TNFAIP8 (Figure 15D) were both down regulated 
in psoriatic non-lesional and lesional epidermal and dermal samples as compared to 
healthy controls. It is important to note that these results show strong correlations with the 
results from PGN stimulated DCs (Figure 11B and Figure 11E, respectively). 
To summarize these results we can conclude that beside the enhanced level of TNF-
α, the elevated expression of TNFAIP6 also has important role in the maintenance of 
chronic inflammation which is characteristic for psoriasis. Furthermore, the down 
regulation of TNFAIP3 and TNFAIP8 strongly suggest that braking mechanisms of 
inflammation are disturbed which may also explain chronic inflammation. 
 As the results obtained from the investigation of psoriatic skin biopsy samples 
demonstrate strong correlation with the results of PGN stimulated DCs  we also compared 
the relative gene expression pattern of other inflammation-related effector molecules in 
plaque-type psoriasis and the ex vivo PGN stimulated DCs. It is well known that the 
enhanced level of Th1 and Th17 cytokines have essential role in the pathogenesis of 
psoriasis by increasing the number of effector T lymphocytes in the skin. As we detected 
significant induction of IL-6 (Figure 10F), IL-17A (Figure 10H) and CXCL8 (Figure 
10B) in DCs after single or prolonged PGN stimulation and considering that elevated 
level of CCL1 (Figure 10E) is also characteristic for psoriasis [85] we conclude that PGN 
stimulated DCs could be used to model the characteristics and the function of IFN-primed 
DCs in psoriasis.  
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Figure 15. Elevated pro inflammatory and decreased anti- inflammatory cytokine expression was 
detected in psoriatic non-lesional and lesional dermis and epidermis (A: TNF-α; B: TNFAIP3 / A20; C: 
TNFAIP6 / TSG6; D: TNFAIP8 / TIPE2). Bars show means ±SEM from 3 individuals. * significantly 
different from age and gender matched healthy controls (Student’s paired t test; * p<0,05). Blue: epidermis; 
green: dermis 
TNF-α blockade down regulates pro inflammatory cytokines at relative gene 
expression and secreted protein level in T+PGN samples 
Beside conventional treatment strategies, TNF-α blocking antibodies became the 
most common therapeutic approaches to cure psoriasis. Thus, and based on our results 
which demonstrate that iDCs after prolonged PGN stimulation show strong correlations 
with psoriatic DCs we aimed to test the impact of TNF-α deprivation at cellular level. For 
this, soluble chimeric monoclonal anti-TNF-α antibody (Remicade, infliximab) was 
added to monocytes in parallel with differentiation procedure as described in materials 
and methods. Although Remicade has a long half-life, to block the PGN induced de novo 
synthesized TNF-α we also added anti-TNF-α antibody in parallel with PGN treatment 
(Figure 6). 
First we monitored the impact of Remicade treatment on the relative gene expression 
pattern of TNF-α (Figure 16A). Single PGN stimulation in combination with Remicade 
treatment resulted in significant relative gene expression up regulation compared with 
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naïve cells (average fold change: 73,36). Similar with only PGN stimulated iDCs 
(average fold change:36,58), prolonged PGN stimulation with Remicade treatment 
resulted in significant relative gene expression down regulation as compared with 
N+PGN samples (average fold change: 16,8). In N+PGN samples Remicade treatment 
resulted in more robust relative gene expression up regulation (average fold change 
73,36)  than only single PGN stimulated cells (average fold change: 36,58). In T+PGN 
samples TNF-α block 
ade had no impact on the average fold change as compared with only PGN stimulated 
samples. 
Single or prolonged PGN stimulation resulted in significant relative gene expression 
up regulation in case of IL-6 (Figure 16B) compared with naïve cells (average fold 
change: 108,32 and 208,04, respectively). Interestingly, in T+PGN samples Remicade 
treatment resulted in robust relative gene expression down regulation of IL-6 compared 
with prolonged PGN stimulated iDCs (average fold change: 76,93 versus 208,04, 
respectively, p=0,1172). 
As mentioned earlier, PGN stimulation results in the up regulation of the relative 
gene expression of CCL1 (Figure 16C; average fold change: 5,69) and a more robust 
relative gene expression up regulation was detected after prolonged PGN stimulation 
(average fold change: 99,13). Importantly, Remicade treatment resulted in relative gene 
expression down regulation in N+PGN samples (average fold change: 0,6; p=0,1157). 
Although Remicade treatment in T+PGN samples moderately up regulated the relative 
gene expression of CCL1, the average fold change was significantly less than only PGN 
treated iDCs. To analyze this result at secreted protein level, ELISA measurement from 
cell culture supernatants was performed (Figure 16D). ELISA measurements strongly 
supported our QRT-PCR results: the blockade of secreted TNF-α significantly down 
regulated secreted CCL1 level in T+PGN samples compared with iDCs after prolonged 
PGN stimulation. 
These data strongly suggest that the blockade of secreted TNF-α has significant 
impact on the relative gene expression pattern of other cytokines. Corresponding to 
previous articles [86], [87], Remicade treatment robustly down regulates the relative gene 
expression of IL-6 which strongly suggest the fact that IL-6 together with TNF-α has 
central role in inflammatory responses. It has not been published yet, that Remicade 
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treatment significantly decreased the relative gene expression and the secreted protein 
level of CCL1 as compared with only PGN stimulated iDCs. Our previous findings at 
both relative gene expression and secreted protein level strongly suggest that ex vivo PGN 
stimulated DCs are identical with IFN-α primed psoriatic DCs, moreover, ex vivo PGN 
stimulated iDCs could be used to model the physiology of IFN-α primed psoriatic DCs. 
Furthermore, beside TNF-α, other inflammation-related effector molecules, such as IL-6, 
CCL1 and TNFAIP6 have pivotal role in the pathogenesis of psoriasis. The results of 
secreted TNF-α blockade massively suggest that these cytokines can be used as a target 
gene/protein to treat plaque-type psoriasis. 
 
Figure 16. TNF-α deprivation results significant impact on the expression pattern of pro inflammatory 
mediators in the presence of S. aureus derived PGN at relative gene expression and secreted protein level, 
respectively. (A: the relative gene expression of TNF-α, B: the relative gene expression of IL-6; C: the 
relative gene expression of CCL1; D: secreted protein level of CCL1) Bars show means ± SEM from at 
least 3 independent experiments. * significantly different (Student’s paired t test in relative gene expression 
studies and One –Way ANOVA following Neuman-Keuls post-hoc test in secreted protein measurements; * 
p<0,05) Purple: without Remicade; pink: with Remicade 
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Discussion 
In mammals DCs have pivotal role in orchestrating innate and adaptive immune 
response against impending pathogens. For this, they have sentinel function at the 
periphery by sensing and taking up pathogens/antigens [6]. Pathogen/antigen uptake 
initiates maturation processes which transform immature DCs into mDCs that are 
professional antigen presenting cells (APCs).  Professional APCs present pathogen-
derived antigens through their MHC II molecules to naïve T lymphocytes at the 
proximate lymph nodes and initiate adaptive immune response [88], [24]. 
PGN stimulation and re-stimulation has appreciable impact on the gene expression 
profile of primary human iDCs 
In order to get a global view on the alterations caused by single or prolonged PGN 
stimulation on iDCs, SAGE-Seq experiments were carried out. Bioinformatics analysis of 
SAGE-Seq results confirmed our hypothesis that the TLR2 stimulation with its respective 
ligand has strong impact on iDCs, as the gene expression of as many as 5411 genes were 
significantly changed (Figure 8). In this study we mainly focused on those 566 genes 
which expression patterns were uniquely different between single or prolonged PGN 
stimulation, because they - presumably - represent the differences between acute and 
persistent infection. 
Pathway analysis was carried out to characterize the potential relevance of the 
alterations caused by single or prolonged PGN stimulation. Both BioProc and Kegg 
pathway analysis strongly suggest that iDCs maintain critical balance between 
inflammation and tolerance in order to maintain the transient nature of the immune 
response and to protect the host from immune pathologic side effects caused by extended 
inflammation. In contrary, PGN stimulation resulted in the down regulation of numerous 
members of the cell cycle and energy production pathways, which supports the fact that 
antigen challenge resulted in DC maturation characterized by functional changes rather 
than the numeral expansion of iDCs. It is also important to note that PGN stimulation 
results in the induction of autoimmune inflammatory disease pathways, such as systemic 
lupus erythematosus or autoimmune thyreoid disease. 
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The relative gene expression profile of pro-inflammatory mediators after single or 
prolonged PGN stimulation show strong correlations with autoimmune diseases 
Chemokines are small secreted proteins which have pivotal role in the migration and 
the organ specific homing of distinct leukocyte subsets in vivo [89], [90]. In accordance 
with SAGE-Seq results QRT-PCR validation demonstrated that single or prolonged PGN 
stimulation significantly up regulates the relative gene expression of the majority of pro-
inflammatory cytokines/chemokines, such as CXCL8 (Figure 10B), CCL1 (Figure 10E), 
IL-6 (Figure 10F) and IL-17A (Figure 10H). Beside their central role in pathogen 
clearance, the robust induction of these cytokines is also characteristic for autoimmune 
diseases. It is not surprising that enhanced IL-17A level was detected in iDCs, because 
this cytokine is essential in T cell dependent immune response, and it was first described 
in CD4
+
 T lymphocytes [91]. Furthermore, this cytokine is able to induce IL-6, CXCL8 
and GM-CSF production by fibroblasts, and enhanced CXCL8 and TNF-α production by 
macrophages [92]. Moreover, the role of IL-17A is not limited to the immune defense 
against extracellular pathogens [93], [94], [95], since elevated IL-17A level was detected 
in samples from inflammation-related diseases, such as synovial fluids of patients with 
rheumatoid arthritis [96], colon biopsies from inflammatory bowel disease [97], and in 
affected skin subjects with nickel induced contact dermatitis or psoriasis [98]. Based on 
the model of the pathogenesis of psoriasis described by Farkas and Kemény [36] it is not 
surprising that ixekizuimab (humanized IgG4 monoclonal antibody against IL-17A) is 
successfully used to treat moderate to severe plaque type psoriasis [44].  
Identically with the previously mentioned chemokines, SAGE-Seq data evidenced 
significant tag enrichment after single or prolonged PGN stimulation in case of IL-23. 
The expression of this cytokine can be activated by IL-6 and TGF-β and it is involved in 
the development of Th17 cells [99], [100], [101], [102]. Other reports demonstrated that 
the relative gene expression of IL-23 is significantly increased in psoriatic lesional 
epidermis compared to non-lesional biopsy samples, moreover, the secreted IL-23 level 
by monocytes and dendritic cells is unusually high in psoriatic patients [103], [104].  
Beside psoriasis, enhanced IL-23 level is also characteristic for other autoimmune 
diseases, such as systemic lupus erythematosus [105], [106], rheumatoid arthritis [107], 
or inflammatory bowel disease [108]. 
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In contrary with these inflammation-related effector molecules, our data showed that 
prolonged PGN stimulation significantly down regulated the expression level of CCL18 
as compared with single PGN stimulation, a phenotype that we categorized as tolerizeable 
expression. Enhanced CCL18 level is characteristic for atopic dermatitis where CCL18 
positive dendritic-like cells are observed in the dermis [109]. In that study, Pivarcsi and 
his colleagues also demonstrated that PGN stimulation significantly up regulated the 
relative gene expression of CCL18 in Langerhans cells and intestinal-type DCs [109].  
Identically with CCL18, we also demonstrated the tolerizeable expression pattern of 
TNF-α (Figure 11A and F). TNF-α has pivotal role in the early immune response against 
invading pathogens [110] thus, our findings showing the rapid induction of its gene 
expression after single PGN treatment is not surprising. The role of TNF-α is not limited 
to acute-phase response, it is also essential in the induction of apoptosis [111], moreover, 
enhanced TNF-α level has also been associated with a wide variety of diseases, such as 
cancer [112], bipolar disorder [113] and autoimmune diseases such as multiple sclerosis, 
systemic lupus erythematosus, psoriasis and Crohn disease [114].  
Because of the diverse function of TNF-α and its tolerizeable expression pattern after 
prolonged PGN stimulation we also determined the expression pattern of the members of 
the TNF-α superfamily. Single or prolonged PGN stimulation resulted in significant 
relative gene expression up regulation in case of TNFSF15 (Figure 11D). This cytokine 
shows the most conserved architecture compared to TNF-α based on the presence of 
conserved subdomains [115]. As TNFSF15 is a potent inducer of the effector mechanisms 
of T lymphocytes [116] it is not surprising that it has pivotal role in the pathogenesis of 
Crohn disease [117], [118] and psoriasis [57].  
The tolerizeability of CCL18 together with CXCL9 (Figure 10C), CXCL10 (Figure 
10D) and TNF-α (Figure 11A and F) strongly suggest the induction of tolerogenic 
mechanisms rather than inflammation in order to prevent the host against the side effects 
of extended inflammation. Furthermore, the enhanced expression levels of those genes 
which are involved in the pathogenesis of psoriasis strongly support our hypothesis that 
prolonged PGN stimulation not only models persistent infection but it is a useful model to 
investigate psoriatic dendritic cells. This is particularly important since it is almost 
impossible to separate Langerhans cells from psoriatic skin samples, thus the 
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characterization of the gene expression pattern of these cells was only possible using ex 
vivo in situ hybridization. 
Tryptophan deprivation has central role in the control of Staphylococcal infection 
and the induction of autoimmune inflammatory diseases 
In this study we demonstrated that PGN stimulation resulted in significant relative 
gene expression up regulation of IDO (Figure 13B) and Kynu (Figure 13A) which are 
involved in tryptophan breakdown [79] (Figure 17). 
 
Figure 17. Tryptophan degradation pathway [79] 
More than ten years ago it was demonstrated that the up regulation of typtophan 
breakdown confers antiparasitic and antimicrobial effector functions of macrophages, 
monocytes, fibroblasts and epithelial cells [75]. Furthermore, tryptophan deprivation 
interferes with Chlamydia trachomatis (Virok, Filkor et al unpublished data), which is a 
tryptophan auxotroph bacteria [119], [120]. 
The induction of tryptophan catabolism is not limited to the elimination of invading 
pathogens, it also has central role in the inhibition of T cell proliferation [121], [122]. 
Upon stimulation with Th1 cytokines such as IFN-γ and TNF-α the expression of IDO 
can be induced in PBMCs [123], [124]. Accordingly, it is not surprising that enhanced 
IDO activity can be detected in a wide variety of Th1 mediated inflammatory diseases 
such as inflammatory bowel disease [125] or psoriasis [79]. 
Based on these facts, the significant up regulation of the tryptophan catabolic 
pathway after single and prolonged PGN stimulation not only suggests the induction of 
the adequate immune response against invading pathogens, but it strongly supports our 
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hypothesis that prolonged PGN stimulation models inflammatory diseases such as 
psoriasis. 
PGN stimulation has distinct effect on the relative gene expression of the negative 
regulators of inflammatory processes 
As mentioned earlier, immune response must be strictly regulated in order to protect 
the host against the serious side effects of extended inflammation. The mediators which 
are involved in this phenomenon can be divided into two groups based on their regulating 
capacity [60], [61], [62]. 
The first class of these regulatory molecules includes inhibitory cytokines and the 
negative regulators of the TLR dependent signaling pathway which limits the strength of 
immune activation. In our model, PGN stimulation resulted in significant relative gene 
expression up regulation of IL-10 (Figure 10G). This cytokine has pleiotropic effects in 
the regulation of the immune response and inflammatory processes, moreover, it has been 
associated with a wide variety of autoimmune and inflammation-related diseases [126]. In 
addition, it is also over expressed in metastatic melanoma [127] where enhanced IL-10 
level has an essential role in the down regulation on the immune response against tumor 
cells. Our data strongly suggest that DCs maintain a critical balance between 
inflammation and tolerance upon Staphylococcal infection.  
Because of the tolerizeable expression of TNF-α and its pivotal role in pathogen 
elimination and pathogenesis of autoimmune diseases we also determined the expression 
pattern of the members of TNF-α superfamily. Identically with the expression of pro-
inflammatory molecule TNFSF15, significant relative gene expression up regulation was 
detected in case of TNFAIP6 (Figure 11C) which is a multifunctional cytokine. Our data 
show strong correlations with those previous reports where LPS stimulation resulted in a 
dose-dependent up regulation of TNFAIP6 in primary macrophages [128]. Although 
enhanced TNFAIP6 level was demonstrated in numerous inflammation-related diseases 
[58], no correlations between the relative gene expression level of TNFAIP6 and psoriasis 
has been reported so far. 
Although TNFAIP3 (Figure 11B) is also an important negative regulator of the 
inflammatory response, in our model it has a similar relative gene expression pattern with 
TNF-α. Our findings show strong correlations with a previous report where flagellin-
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mediated TLR5 induction resulted in abundant TNFAIP3 expression in intestinal 
epithelial cells which was also demonstrated in an in vivo acute colitis model in mice. 
This report also showed that the enhanced TNFAIP3 expression does not influence 
tolerance induced with flagellin restimulation [129]. 
In case of TNFAIP8 (Figure 11E) PGN stimulation resulted in relative gene 
expression down regulation in both iDCs and mDCs. In thymocytes, the down regulation 
of TNFAIP8 effectively protected the cells against glucocorticoid induced apoptosis 
[130]. Furthermore, the decreased expression level of TNFAIP8 establishes the 
significantly enhanced level of pro-inflammatory effector molecules such as CXCL8, IL-
6, CCL1 and IL-17A [67], which is in good agreement with our observations, showing a 
reversible expression of TNFAIP8 with the aforementioned pro-inflammatory molecules. 
Beside the previously mentioned negative regulators from the TNF-α induced 
proteins, SOCS proteins also have essential role in the inhibition of extended 
inflammation [71], because they are feedback inhibitors of JAK/STAT signaling cascade 
[131]. Moreover, the absence of SOCS proteins in DCs results in the aberrant activation 
of the adaptive immune system which finally leads to the development of autoimmunity 
[72]. The tolerizeability of SOCS1 (Figure 12A) and SOCS2 (Figure 12B) strongly 
support their central role in the up regulation of the pro-inflammatory cytokines after 
single or prolonged PGN stimulation [73]. In case of SOCS3 PGN stimulation resulted in 
enhanced relative gene expression after single or prolonged PGN stimulation. A previous 
report demonstrated that the enhanced expression level of SOCS3 from psoriatic 
keratinocytes leads to the resistance to apoptosis [132]. 
The second class of the regulatory molecules is involved in the induction of 
programmed cell death [60]. Apoptosis is essential in the maintenance of the transient 
nature of the immune response and to prevent the host against cancer which can be 
induced by environmental triggering factors Our data demonstrated significant relative 
gene expression down regulation after PGN stimulation in case of Cyclin B2 (Figure 
14A) and Cyclin D1 (Figure 14B). These findings strongly supported by the fact that 
cross-linking of TLR with its respective ligand induces maturation process which is 
characterized by functional differentiation of the antigen presenting cells without numeral 
expansion. PGN stimulation significantly reduced the relative gene expression of FADD 
and TGF-β in both iDCs and mDCs. Importantly, the role of programmed cell death is not 
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limited to the maintenance of tissue homeostasis, it has pivotal role in preventing the 
organism against the development of autoimmune diseases [133]. However, the role of 
FADD is not limited to the initiation of TNF-dependent apoptosis [134] it is a key factor 
in cell proliferation, differentiation, autophagy, genome surveillance and innate immunity 
[135]. Our data show strong correlations with earlier findings showing that the down 
regulation of FADD enhances the relative gene expression of IL-1β, IL-6, IL-10 and 
TNF-α in mouse epidermis [136]. 
 
The down regulation of the anti-inflammatory members in TNF-α superfamily has 
essential role in the pathogenesis of psoriasis  
Beside keratinocyte hyperproliferation, extended inflammation and immune cell 
infiltration are also hallmarks of psoriasis [137]. The abnormalities leading to psoriasis 
development remain controversial; however, the cross-talk between keratinocytes and T 
lymphocytes represents a necessary step during the course of the disease [138]. Figure 18 
shows the schematic illustration of the pathogenesis of plaque-type psoriasis integrating 
those cytokines (i.e. IL-1β, IL-6, TNF-α and IFN-γ) and cell types which are involved in 
the pathogenesis of this disease [84]. According to this model dermal DCs from psoriatic 
lesions drive the cytokine production toward Th1 and Th17 cytokines [139], [140]. 
 
Figure 18. The brand new model of the pathogenesis of psoriasis [36] 
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In accordance with the literature [82], [83] in psoriatic non-lesional and lesional skin 
biopsy samples significantly up regulated TNF-α and CXCL-8 (Szasz et al, manuscript in 
preparation) levels were detected. In psoriatic skin samples slightly up regulated 
TNFAIP6 relative gene expression level is characteristic. TNFAIP6 was first detected in 
fibroblasts under the stimulation of TNF-α [141]. This glycosaminoglycan-binding 
protein [142], [143] has role in experimental model of arthritis [144], [145], [146], acute 
myocardial infarction [147] and chemically burned rat cornea [148], [149]. These facts 
together with our results strongly suggest that first, TNFAIP6 is one of the key molecules 
in the pathogenesis of psoriasis, and, second, our model is a useful tool in mimicking the 
expression pattern of psoriatic DCs. 
In psoriatic skin samples, the relative gene expression of TNFAIP3 was significantly 
down regulated as compared to healthy skin. Originally, TNFAIP3 was identified as a 
TNF-α inducible gene which functions as negative feedback inhibitor of TNF-α signaling 
[150], [151] by inhibiting NF-κB mediated immune response [63]. Furthermore, genome-
wide association studies have revealed associations between TNFAIP3 and psoriasis 
[152], [153]. Based on these facts our data strongly suggest that the significantly 
decreased level of TNFAIP3 has crucial role in the maintenance of enhanced level of pro-
inflammatory cytokines in psoriatic lesions which serve as a homing signal of infiltrating 
leukocytes. 
TNFAIP8 is also an essential negative regulator of inflammation and immune 
homeostasis by down regulating the T cell receptor and TLR signaling [67] and, as it was 
mentioned earlier, down regulation of this gene is involved in the protection against 
apoptosis [130]. To the best of our knowledge we were the first who demonstrated the 
significant down regulation of TNFAIP8 in psoriatic dermis and epidermis at a relative 
gene expression level which in accordance with the literature explains the enhanced 
cytokine production and the decreased sensitivity to pro-apoptotic processes which is 
characteristic for psoriasis. 
The blockade of soluble TNF-α significantly reduces the relative gene expression and 
secreted protein level of pro-inflammatory cytokines 
Based on the more particular understanding of the pathogenesis of psoriasis at a 
molecular level, the inhibition of pro-inflammatory mediators with antibodies or soluble 
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receptors became the mainstream therapy to treat psoriasis. As TNF-α plays central role 
in the pathogenesis of psoriasis, it represents an active target for biologic therapies, 
moreover, a wide variety of TNF blocking agents have been accepted by FDA and are 
widely used to treat psoriasis [47]. 
We showed that Remicade treatment markedly reduced the relative gene expression 
of IL-6 after PGN stimulation (Figure 16B). This result show strong correlations with 
those earlier findings where the blockade of TNF-α by Remicade significantly reduced 
the relative gene expression of acute-phase proteins such as IL-1β and IL-6 [86]. Soluble 
TNF-α blockade also significantly down regulated CCL1 at relative gene expression 
(Figure 16C) and secreted protein level (Figure 16D) after prolonged PGN stimulation. 
To the best of our knowledge, we were the first who demonstrated the negative impact of 
TNF-α blockade on the expression of CCL1. 
Taken these findings together, our data strongly suggest that in inflammatory 
conditions, enhanced TNF-α level robustly up regulates other cytokines and chemokines 
which have pivotal role in the maintenance of chronic inflammation. When enhanced 
TNF-α level is blocked by Remicade treatment, the expression level of the other effector 
mechanisms are down regulated, that is why Remicade successfully used to treat a wide 
variety of autoimmune inflammatory diseases [33], [154], [155]. 
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Summary 
 
In order to get a global view on the gene expression pattern of primary human iDCs 
after single or prolonged PGN stimulation, SAGE-Seq experiments were performed. 
Bioinformatics analysis of SAGE-Seq data evidenced that single or prolonged PGN 
stimulation resulted in significant alterations on  the relative gene expression of altogether 
5411 genes (p<0,05). In this study we mainly focused on those 566 genes which uniquely 
changed between N+PGN and T+PGN samples because they represent the differences 
between acute and persistent Staphylococcal infection at a relative gene expression level.  
To characterize the potential relevance of these alterations pathway analysis was 
carried out which demonstrated massive enrichment of pathways from the function group 
“Immune response”, “Apoptosis”, “Cell cycle”, “Motion” and “Energy production”. 
Based on the results of the pathway analysis we investigated the expression patterns of 
individual tags. From the tags we were mostly interested in tolerizeable tags 
(tolerizeability means that single PGN stimulation results in a robust induction in the 
relative gene expression compared with naïve cells, however in T+PGN samples 
significant relative gene expression down regulation was detected compared with N+PGN 
cells) because the decreased relative gene expression level after prolonged PGN 
stimulation plays role in the prevention of the host against the development of serious 
side effects resulting from uncontrolled inflammation. Taken these findings together our 
experimental model together with SAGE-Seq is a valuable approach to monitor the 
impact of acute and persistent infection. 
We also aimed to validate SAGe-Seq results on a set of genes. Based on the results of 
pathway analysis we have chose the members of “Immune response”, “Apoptosis”, and 
“Cell cycle” which were more accurately analyzed at relative gene expression and 
secreted protein level. The validation procedure was carried out on mDCs as well, 
because the presence of foreign antigens together with the inflammatory milieu induces 
maturation process which leads to enhanced antigen presenting capacity. In accordance 
with the results of SAGE-Seq experiments the QRT-PCR and ELISA-based 
validation procedure demonstrated that: 
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  after single or prolonged PGN stimulation the host cell maintain critical 
balance between inflammation and tolerance to eliminate impending pathogens 
and to protect the host against the harmful side effects resulting from 
uncontrolled inflammation 
  the decreased pro-inflammatory cytokine producing capacity of mDCs 
compared with iDCs 
  PGN stimulation results in the induction of the pro-inflammatory mediators 
from the TNF-α superfamily, yet we demonstrated the tolerizeable nature of  
TNF-α and TNFAIP3, however PGN treatment significantly down regulated the 
relative gene expression of TNFAIP8 (which has anti-inflammatory role) 
compared with naïve cells 
  the over expression of the tryptophan catabolizing enzymes has role in the 
control of acute and more interestingly in persistent Staphylococcal infection 
  the enhanced relative gene expression level of SOCS1 and SOCS3 may be 
responsible for down regulation of pro-inflammatory effector molecules in 
mDCs 
  at the same time the decreased level of SOCS1 and SOCS2 in iDCs after 
prolonged PGN stimulation strongly explains the enhanced production of 
inflammation-related effector molecules 
  acute and persistent Staphylococcal infections decreases cell division cycle by 
down regulating the relative gene expression level of cyclins 
  the reduced relative gene expression level of pro-apoptotic genes suggest the 
induction of survival mechanisms which may lead to the elimination of invading 
pathogens 
Although the pathogenesis of psoriasis has not fully understood yet, the 
immunological basis of the disease has been demonstrated. It is well known that TNF-α 
has pivotal role in the pathogenesis of this disease, little is known about the other 
members of the TNF-α superfamily. To investigate their potential role we performed 
QRT-PCR experiments on lesional and non-lesional epidermal and dermal skin biopsy 
samples from psoriatic patients. To summarize these results we can conclude that 
beside the enhanced level of TNF-α, the elevated expression of TNFAIP6 also has 
important role in the maintenance of chronic inflammation which is characteristic 
for psoriasis. Furthermore, the down regulation of TNFAIP3 and TNFAIP8 strongly 
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suggest that braking mechanisms of inflammation are disturbed which may also 
explain chronic inflammation. As we detected significant induction of IL-6, IL-17A 
and CXCL8 in DCs after single or prolonged PGN stimulation and considering that 
elevated level of CCL1 is also characteristic for psoriasis we conclude that PGN 
stimulated DCs could be used to model the characteristics and the function of IFN-
primed DCs in psoriasis.  
Beside conventional treatment strategies, TNF-α deprivation by blocking antibodies 
became the most common therapeutic approach to cure psoriasis. Thus and based on our 
results which demonstrate that iDCs after prolonged PGN stimulation show strong 
correlations with psoriatic DCs we aimed to test the impact of TNF-α deprivation by 
Remicade (infliximab) which has significant impact on the relative gene expression 
pattern of other cytokines. It has not been published yet, that Remicade treatment 
significantly decreased the relative gene expression and secreted protein level of 
CCL1 as compared with only PGN stimulated iDCs. Our previous findings strongly 
suggest that ex vivo PGN stimulated DCs are identical with IFN-α primed psoriatic 
DCs. This result massively suggest that these cytokines can be used as a target 
gene/protein to treat plaque-type psoriasis. 
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